Application Sponsors
ANDA 201823 | WATSON LABS INC | |
Marketing Status
Discontinued | 001 |
Discontinued | 002 |
Application Products
001 | TABLET;ORAL | EQ 0.5MG BASE | 0 | RASAGILINE MESYLATE | RASAGILINE MESYLATE |
002 | TABLET;ORAL | EQ 1MG BASE | 0 | RASAGILINE MESYLATE | RASAGILINE MESYLATE |
FDA Submissions
N/A; Not Applicable | ORIG | 1 | AP | 2013-07-01 | |
Submissions Property Types
CDER Filings
WATSON LABS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 201823
[companyName] => WATSON LABS INC
[docInserts] => ["",""]
[products] => [{"drugName":"RASAGILINE MESYLATE","activeIngredients":"RASAGILINE MESYLATE","strength":"EQ 0.5MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"RASAGILINE MESYLATE","activeIngredients":"RASAGILINE MESYLATE","strength":"EQ 1MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"07\/01\/2013","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Not Applicable","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2013-07-01
)
)